Office of the Director, National Institutes of Health; Notice of Meeting, 28529 [2014-11251]
Download as PDF
Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices
reorganization plans for the NIDA
extramural program in establishment of
a Division of Extramural Research based
on initial discussions, public comment
and feedback at the NIDA Advisory
Council on Drug Abuse Meeting on May
7th. The proposal seeks to clearly
delineate functions and streamline the
services provided within the Office of
the Director, as well as capitalize on
emerging scientific opportunities, while
reducing barriers to scientific and
interdisciplinary collaboration.
Members of the public wishing to
attend must view the discussion via
webex link https://nidaevents.webex.com/nida-events/onstage/
g.php?d=660244762&t=a and enter the
audio conference information above
from their telephone. Upon opening the
link provided, please contact your IT
support group for assistance in
uploading any necessary drivers (e.g.
MBR2 player) prior to the start of this
event.
Dated: May 8, 2014.
Nora Volkow,
Director, National Institute on Drug Abuse,
National Institutes of Health.
[FR Doc. 2014–11253 Filed 5–15–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
EMCDONALD on DSK67QTVN1PROD with NOTICES
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee to the Director,
National Institutes of Health.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Mar<15>2010
20:00 May 15, 2014
Jkt 232001
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: June 5–6, 2014.
Open: June 05, 2014, 9:00 a.m. to 4:15 p.m.
Agenda: NIH Director’s Report, NIH
Updates, and other business of the
committee.
Place: National Institutes of Health,
Building 1, Room 126, 1 Center Drive,
Bethesda, MD 20892.
Closed: June 05, 2014, 4:15 p.m. to 5:15
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 1, Room 126, 1 Center Drive,
Bethesda, MD 20892.
Open: June 06, 2014, 9:00 a.m. to 12:00
p.m.
Agenda: ACD Working Group reports, NIH
updates, and other business of the
committee.
Place: National Institutes of Health,
Building 1, Room 126, 1 Center Drive,
Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 103, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: May 12, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–11251 Filed 5–15–14; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
28529
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group Kidney, Urologic and
Hematologic Diseases D Subcommittee.
Date: June 18–19, 2014.
Open: June 18, 2014, 8:00 a.m. to 8:30 a.m.
Agenda: To review policy and procedures.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Closed: June 18, 2014, 8:30 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Closed: June 19, 2014, 8:00 a.m. to 12:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Barbara A. Woynarowska,
Ph.D., Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 754, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 402–7172, woynarowskab@
niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group Diabetes,
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: June 18–20, 2014.
Open: June 18, 2014, 3:00 p.m. to 3:30 p.m.
Agenda: To review policy and procedures.
Place: The Palmer House Hilton, 17 East
Monroe Street, Chicago, IL 60603.
E:\FR\FM\16MYN1.SGM
16MYN1
Agencies
[Federal Register Volume 79, Number 95 (Friday, May 16, 2014)]
[Notices]
[Page 28529]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11251]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Advisory Committee to the Director, National Institutes of Health.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Advisory Committee to the Director, National
Institutes of Health.
Date: June 5-6, 2014.
Open: June 05, 2014, 9:00 a.m. to 4:15 p.m.
Agenda: NIH Director's Report, NIH Updates, and other business
of the committee.
Place: National Institutes of Health, Building 1, Room 126, 1
Center Drive, Bethesda, MD 20892.
Closed: June 05, 2014, 4:15 p.m. to 5:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 1, Room 126, 1
Center Drive, Bethesda, MD 20892.
Open: June 06, 2014, 9:00 a.m. to 12:00 p.m.
Agenda: ACD Working Group reports, NIH updates, and other
business of the committee.
Place: National Institutes of Health, Building 1, Room 126, 1
Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1, Room 103, Bethesda, MD 20892, 301-496-4272,
woodgs@od.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://acd.od.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: May 12, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-11251 Filed 5-15-14; 8:45 am]
BILLING CODE 4140-01-P